Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ January 28, 2023 ] TYR Sport Signs Prodigy Katie Grimes. Los Angeles Biotech News
  • [ January 27, 2023 ] Ayal Willner, MD, is recognized by Continental Who’s Who Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15(c) Announcement – Rule 15 Proposal to Horizon Equity Award Holders and Participants in the Horizon Employee Share Purchase Plan Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15 (c) Announcement – Horizon Therapeutics plc Los Angeles Biotech News
  • [ January 27, 2023 ] Research Technician I – Zymo Research – Irvine, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsSEC Qualifies OriginClear Reg A+ Public Offering

SEC Qualifies OriginClear Reg A+ Public Offering

April 6, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on SEC Qualifies OriginClear Reg A+ Public Offering
LOS ANGELES--(BUSINESS WIRE)---- $OCLN #investorwater--SEC Qualifies OriginClear Reg A+ Public Offering. Company proceeds with plan to publicly offer up to $19M of preferred stock to qualified investors

Click to view original post

Previous

Accelerated Enrollment Solutions and Science 37 Collaborate to Provide Virtual Trial Access to Patients Globally

Next

Milken Institute Global Conference Rescheduled to October

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered